subsequent target product and was synthesized as previously described (1, 2). First, the primary alcohol of diol 2 was selectively protected through reaction with tertbutyldiphenyl chlorosilane to produce compound 3. Next, ether bond formation using oleyl triflate was performed to afford fully protected glycerol 4, followed by deprotection of the p-methoxybenzyl (PMB) group to provide the free alcohol of 5. Phosphoramidite chemistry was then used to install the choline phosphodiester of 7, at which time it was found that the cyanoethyl protecting group on the phosphate was deprotected in situ.
When followed by mass spectrometry, this was found to happen during the process of purifying compound 7. The yield for the 2-step production of 7 is somewhat low, likely due to the challenges associated with forming mixed phosphodiesters and the purification of the lyso-lipid product. Finally, the removal of the silyl protecting group of 7 yielded LPC analog 1. It is worth mentioning that a similar approach was also pursued that involved a glycerol precursor with opposite stereochemistry, initial removal of the silyl group, and deprotection of the PMB in the final step. However, this alternative route led to significant challenges in purifying the final product, and was thus abandoned in favor of the route described above. LPC analog 1 has previously been reported in enantiomerically pure (3) as well as racemic form (4) using different synthetic routes.
3-O-(4-
synthesized from S-glycerol acetonide (purchased from AK Scientific, Inc.) according to a known procedure (1, 2). Diol 2 (0.430g, 2.026mmol) was then dissolved in dry N,Ndimethylformamide (20mL), to which was added tert-butyldiphenyl chlorosilane (0.525mL, 2.026mmol), followed by imidazole (0.359g, 5.270mmol). The reaction mixture was next allowed to stir at room temperature overnight. The solvent was then concentrated under reduced pressure and the resulting residue was dissolved in chloroform (100mL) and washed with water (2 x 50mL). The organic layer was then dried with magnesium sulfate and the solvent evaporated to yield the crude product.
Purification via column chromatography with silica gel and gradient elution with 15-35% ethyl acetate/hexanes yielded 3 as a colorless oil (0.73g, 80%). The product matched previous characterizations (5 
1-O-(tert-Butyldiphenylsilyl)-2-oleyl-3-O-(4-Methoxybenzyl)-sn-glycerol (4)
The procedure for synthesis of 4 was modified from similar ether-tail forming reactions (6).
Compound 3 (0.660g, 1.465mmol) was dissolved in dry dichloromethane (40mL), to which was added 1,8-Bis(dimethylamino)naphthalene (proton sponge, 1.10g, 5.15mmol) and oleyl triflate (2.900g, 7.240mmol), which was prepared from a known procedure (7). The solution was next heated to reflux and allowed to stir overnight. The solvent was then removed under reduced pressure to yield the crude product 4, which was purified by column chromatography with silica gel and gradient elution with 5-10% acetone/hexanes to yield 4 as a yellowish oil (0.714 g, 71% 
1-O-(tert-Butyldiphenylsilyl)-2-oleyl-sn-glycerol (5)
Compound 4 (0.325g, 0.463mmol) was combined with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ, 0.315g, 1.389mmol) in dichloromethane (10mL) and water (1mL). The reaction mixture was then stirred at rt. After 10h, saturated sodium bicarbonate (100mL) was added to quench the reaction, and the resulting solution was then extracted twice with chloroform (2 x 100mL). The organic layers were then combined and dried with magnesium sulfate and the solvent removed by rotary evaporation to yield the crude product, which was carried on to the next step without further purification. Column chromatography was performed using 230-400 mesh silica gel purchased from Sorbent Technologies (Atlanta, GA). NMR spectra were obtained using a Varian Mercury 300 spectrometer. Mass spectra were obtained with a Voyager DE MALDI-TOF spectrometer (PerSeptive Biosystemes, Framingham,MA).
1-O-(tert-Butyldiphenylsilyl)-2-oleoyl-sn-glycero-3-phosphocholine (7)
Crude
